(MBCC) Northern Lights Fund Trust - Overview
Etf: Stocks, S&P, Revenue, Income
Dividends
| Dividend Yield | 0.27% |
| Yield on Cost 5y | 0.40% |
| Yield CAGR 5y | 77.80% |
| Payout Consistency | 63.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.9% |
| Relative Tail Risk | 5.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -10.72 |
| Character TTM | |
|---|---|
| Beta | 0.863 |
| Beta Downside | 0.927 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.59% |
| CAGR/Max DD | 0.79 |
Description: MBCC Northern Lights Fund Trust December 16, 2025
The Northern Lights Fund Trust IV – Monarch Blue Chips Core ETF (BATS: MBCC) is a U.S.-based large-growth ETF that allocates at least 80 % of its net assets to the constituents of its underlying index, which selects well-established S&P 500 companies across multiple sectors based on fundamental metrics such as revenue, revenue growth, net income and net-income growth.
As of the latest filing (Q3 2024), MBCC carries an expense ratio of 0.12 % and manages roughly $1.3 billion in assets. Its top ten holdings-Apple, Microsoft, Amazon, Alphabet, Nvidia, Meta Platforms, Johnson & Johnson, UnitedHealth, Visa and Procter & Gamble-represent about 35 % of the portfolio, with technology and health-care sectors accounting for the largest weightings. Recent performance shows a 12-month total return of ~18 % versus the S&P 500’s ~14 % over the same period, reflecting the fund’s tilt toward high-growth, earnings-expanding firms. Key macro drivers include U.S. consumer-spending trends, corporate-profit growth, and the Federal Reserve’s monetary policy stance, all of which influence the earnings momentum of the underlying large-cap growth stocks.
For a deeper, data-driven comparison of MBCC’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
What is the price of MBCC shares?
Over the past week, the price has changed by -0.26%, over one month by -0.71%, over three months by +1.13% and over the past year by +2.89%.
Is MBCC a buy, sell or hold?
What are the forecasts/targets for the MBCC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.8 | 9.6% |
MBCC Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 143.9m USD (143.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 143.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 143.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.09% (E(143.9m)/V(143.9m) * Re(9.09%) + (debt-free company))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)